Target audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in risk management.
LEARNING OBJECTIVES1. Summarize the meaning of the term "therapeutic nondisclosure" in the context of medical oncology practice.2. Classify the reasons for variations in disclosure practices around the world.3. Develop strategies for approaching a conversation about disclosure that respects the rights and needs of the patient and family.This article is available for continuing medical education credit at CME.TheOncologist.com. CME CME
ABSTRACTThe term "therapeutic nondisclosure" refers to a clinician's decision to withhold diagnostic or prognostic information from a patient to protect him or her from perceived harm. We present a vignette in which the son of a 75-year-old Italian born immigrant asks her physician to withhold her new diagnosis of advanced myeloma. In the U.S., trends over the last 30 years have been toward more complete disclosure of cancer-related information. This can be attributed to the evolution of research subject protections, the "war on cancer," the civil rights and patient rights movements, and the rise of hospice and palliative care. In other parts of the world, however, therapeutic nondisclosure is still commonly practiced. Here, we de-